1. Home
  2. SGD vs APM Comparison

SGD vs APM Comparison

Compare SGD & APM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGD
  • APM
  • Stock Information
  • Founded
  • SGD 2021
  • APM 2010
  • Country
  • SGD United States
  • APM United Kingdom
  • Employees
  • SGD N/A
  • APM N/A
  • Industry
  • SGD
  • APM Biotechnology: Pharmaceutical Preparations
  • Sector
  • SGD
  • APM Health Care
  • Exchange
  • SGD Nasdaq
  • APM Nasdaq
  • Market Cap
  • SGD 3.4M
  • APM 4.0M
  • IPO Year
  • SGD N/A
  • APM 2018
  • Fundamental
  • Price
  • SGD $2.26
  • APM $0.74
  • Analyst Decision
  • SGD
  • APM
  • Analyst Count
  • SGD 0
  • APM 0
  • Target Price
  • SGD N/A
  • APM N/A
  • AVG Volume (30 Days)
  • SGD 131.4K
  • APM 69.7K
  • Earning Date
  • SGD 01-01-0001
  • APM 12-27-2024
  • Dividend Yield
  • SGD N/A
  • APM N/A
  • EPS Growth
  • SGD N/A
  • APM N/A
  • EPS
  • SGD N/A
  • APM N/A
  • Revenue
  • SGD $173,188.00
  • APM $431,378.00
  • Revenue This Year
  • SGD N/A
  • APM $157,729.10
  • Revenue Next Year
  • SGD N/A
  • APM N/A
  • P/E Ratio
  • SGD N/A
  • APM N/A
  • Revenue Growth
  • SGD N/A
  • APM N/A
  • 52 Week Low
  • SGD $1.45
  • APM $0.46
  • 52 Week High
  • SGD $53.80
  • APM $17.49
  • Technical
  • Relative Strength Index (RSI)
  • SGD 40.85
  • APM 41.12
  • Support Level
  • SGD $2.05
  • APM $0.73
  • Resistance Level
  • SGD $2.40
  • APM $0.78
  • Average True Range (ATR)
  • SGD 0.24
  • APM 0.09
  • MACD
  • SGD 0.05
  • APM 0.04
  • Stochastic Oscillator
  • SGD 26.32
  • APM 64.47

About SGD Safe and Green Development Corporation

Safe & Green Development Corp is a real estate development company that focuses on the development of sites using purpose built, prefabricated modules built from both wood & steel, sourced from one of Safe & Green Holdings factories. The company's business model is flexible and it anticipates developing properties on its own and also through joint ventures in which it partner with third-party equity investors or other developers.

About APM Aptorum Group Limited

Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.

Share on Social Networks: